🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07523958
Recruiting Not applicable

Paraffin Oil for Preventing Tourniquet-Related Skin Lesions in Upper Extremity Surgery

NCT07523958 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-01-12
Last updated
2026-06-04

Condition(s) studied

Pressure InjurySkin LesionsSkin Injury

Investigational drug(s) / intervention(s)

Paraffin Oil

Paraffin Oil: Topical paraffin oil is applied to the skin area before tourniquet placement.

Study summary

This randomized controlled trial aims to evaluate the effectiveness of topical paraffin oil application in preventing tourniquet-related skin lesions in patients undergoing upper extremity surgery. Pneumatic tourniquets are commonly used to provide a bloodless surgical field; however, they may cause skin complications such as erythema, edema, abrasions, blisters, and burns.

In this study, adult patients undergoing elective upper extremity surgery will be randomly assigned to either an intervention group receiving topical paraffin oil application in addition to routine protective dressing or a control group receiving routine care only. Skin integrity will be assessed immediately after tourniquet removal and at 30 and 60 minutes postoperatively using standardized skin assessment criteria.

The findings of this study are expected to contribute to the development of effective, simple, and cost-efficient strategies to prevent tourniquet-related skin complications and improve patient safety and postoperative comfort.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
IInclusion Criteria: * Age ≥18 years * Patients scheduled for elective upper extremity surgery requiring pneumatic tourniquet application * ASA physical status I-III * Body mass index (BMI) \<30 kg/m² * Ability to provide informed consent * Willingness to participate in the study Exclusion Criteria: * Age \<18 years * Known dermatological disease or existing skin lesion at the tourniquet application site * Allergy or sensitivity to paraffin oil or related substances * Severe systemic disease (ASA IV or higher) * Obesity (BMI ≥30 kg/m²) * Emergency surgery * Patients transferred to intensive care postoperatively * Development of major postoperative complications (e.g., hematoma, seroma, nerve injury, significant bleeding) * Inability to communicate or comply with study procedures * Withdrawal from the study at any time

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Kartal Dr. Lütfi Kırdar City Hospital Istanbul, Turkey Istanbul Turkey (Türkiye) Recruiting

More Istanbul Medipol University Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07523958 on ClinicalTrials.gov ↗ ← All trials in Turkey